Concepedia

Dian Kortleve

DK

Statistics

Publications

1

Citations

11

H-Index

1

Active since

2024

Affiliations

Ludwig Cancer Research(Current)

Dian Kortleve is an author at Ludwig Cancer Research specializing in tumor antigens, triple-negative breast cancer therapy, and t cell receptor signaling.

ORCID

Publications per year

2024–2024

1

Publications

1

TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer

Dian Kortleve, Dora Hammerl, Mandy van Brakel et al. · Cancer Discovery · 2024 · 11 citations · Full text

, , +17

1–1 of 1